Literature DB >> 17328055

Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis.

Andrzej Surdacki1, Jens Martens-Lobenhoffer, Alicja Wloch, Ewa Marewicz, Tomasz Rakowski, Ewa Wieczorek-Surdacka, Jacek S Dubiel, Juliusz Pryjma, Stefanie M Bode-Böger.   

Abstract

OBJECTIVE: Similarities between rheumatoid arthritis (RA) and atherosclerosis include endothelial dysfunction (an antecedent of plaque formation) and depletion of circulating bone marrow-derived endothelial progenitor cells. This study was undertaken to test the hypothesis that endothelial progenitor cell depletion and subclinical atherosclerosis in RA may be related to accumulation of an endogenous inhibitor of nitric oxide (NO) synthesis, asymmetric dimethyl-L-arginine.
METHODS: We studied 30 patients with active RA and 20 age- and sex-matched healthy controls. Exclusion criteria were clinically evident atherosclerosis, traditional risk factors, hyperhomocysteinemia, and renal dysfunction. The blood endothelial progenitor cell count was assayed by flow cytometry and expressed as a percentage of lymphocytes. Plasma L-arginine, asymmetric dimethyl-L-arginine, and symmetric dimethyl-L-arginine were measured with liquid chromatography-mass spectrometry. Mean carotid intima-media thickness (IMT) was assessed by B-mode ultrasound.
RESULTS: In RA patients, we found elevated levels of asymmetric dimethyl-L-arginine (mean +/- SD 0.49 +/- 0.07 micromoles/liter versus 0.40 +/- 0.07 micromoles/liter in controls; P < 0.001), a depressed endothelial progenitor cell count (0.039 +/- 0.025% versus 0.063 +/- 0.035%; P < 0.05), and increased IMT (0.65 +/- 0.13 mm versus 0.55 +/- 0.10 mm; P < 0.01), with no differences in levels of L-arginine or symmetric dimethyl-L-arginine. The endothelial progenitor cell count was inversely correlated with the level of asymmetric dimethyl-L-arginine. IMT was positively related to the ratio of asymmetric dimethyl-L-arginine to L-arginine and negatively related to the endothelial progenitor cell count, in univariate and multivariate analyses.
CONCLUSION: Plasma asymmetric dimethyl-L-arginine levels are elevated in RA patients free of cardiovascular disease or risk factors. Asymmetric dimethyl-L-arginine accumulation may contribute to endothelial progenitor cell depletion via depressed NO-dependent endothelial progenitor cell mobilization and/or survival, with consequent impairment of endothelial progenitor cell-mediated endothelial repair, which can promote atherogenesis in RA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328055     DOI: 10.1002/art.22424

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  27 in total

1.  Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.

Authors:  Baris Yilmazer; Tayfun Sahin; Berrin Öztaş Unlu; Hale Maral Kir; Ayse Cefle
Journal:  Rheumatol Int       Date:  2015-02-11       Impact factor: 2.631

2.  Association of colony-forming units with coronary artery and abdominal aortic calcification.

Authors:  Susan Cheng; Kenneth S Cohen; Stanley Y Shaw; Martin G Larson; Shih-Jen Hwang; Elizabeth L McCabe; Roderick P Martin; Rachael J Klein; Basma Hashmi; Udo Hoffmann; Caroline S Fox; Ramachandran S Vasan; Christopher J O'Donnell; Thomas J Wang
Journal:  Circulation       Date:  2010-09-07       Impact factor: 29.690

Review 3.  Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment.

Authors:  Mariana J Kaplan
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

4.  Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study.

Authors:  Gian Luca Erre; Pietro Sanna; Angelo Zinellu; Alessandra Ponchietti; Patrizia Fenu; Salvatore Sotgia; Ciriaco Carru; Antonello Ganau; Giuseppe Passiu
Journal:  Clin Rheumatol       Date:  2010-10-14       Impact factor: 2.980

5.  Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.

Authors:  Parisa Zafari; Ahmadreza Zarifian; Reza Alizadeh-Navaei; Mahdi Taghadosi; Alireza Rafiei; Zahra Samimi; Fatemeh Niksolat
Journal:  Clin Rheumatol       Date:  2019-08-03       Impact factor: 2.980

6.  Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.

Authors:  Peng Wang; Shi-Yang Guan; Shu-Zhen Xu; Hong-Miao Li; Rui-Xue Leng; Xiang-Pei Li; Hai-Feng Pan
Journal:  Clin Rheumatol       Date:  2015-11-27       Impact factor: 2.980

Review 7.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Saurabh S Dhawan; Arshed A Quyyumi
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

Review 8.  Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Jane E Salmon; Mary J Roman
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

Review 9.  Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.

Authors:  Theodoros Dimitroulas; Aamer Sandoo; George D Kitas
Journal:  Int J Mol Sci       Date:  2012-09-26       Impact factor: 5.923

10.  Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis.

Authors:  Manuela Di Franco; Francesca Romana Spinelli; Alessio Metere; Maria Chiara Gerardi; Virginia Conti; Francesca Boccalini; Cristina Iannuccelli; Francesco Ciciarello; Luciano Agati; Guido Valesini
Journal:  Mediators Inflamm       Date:  2012-08-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.